Xiang F - Search Results

1

CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.

Yu M, Liu Y, Xiang F, Li Y, Cullen D, Liao R, Beyer RP, Bammler TK, Chin MT. Yu M, et al. Among authors: xiang f. OMICS. 2009 Dec;13(6):501-11. doi: 10.1089/omi.2009.0086. OMICS. 2009. PMID: 20001863 Free PMC article.

2

Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications for Cardiac Hypertrophy.

Yu M, Xiang F, Beyer RP, Farin FM, Bammler TK, Chin MT. Yu M, et al. Among authors: xiang f. Curr Genomics. 2010 Jun;11(4):287-96. doi: 10.2174/138920210791233117. Curr Genomics. 2010. PMID: 21119893 Free PMC article.

3

The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation.

Sakata Y, Koibuchi N, Xiang F, Youngblood JM, Kamei CN, Chin MT. Sakata Y, et al. Among authors: xiang f. J Mol Cell Cardiol. 2006 Feb;40(2):267-73. doi: 10.1016/j.yjmcc.2005.09.006. Epub 2005 Oct 19. J Mol Cell Cardiol. 2006. PMID: 16242143

4

CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6.

Shirvani S, Xiang F, Koibuchi N, Chin MT. Shirvani S, et al. Among authors: xiang f. Biochem Biophys Res Commun. 2006 Jan 6;339(1):151-6. doi: 10.1016/j.bbrc.2005.10.190. Epub 2005 Nov 9. Biochem Biophys Res Commun. 2006. PMID: 16293227

5

Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.

Xiang F, Sakata Y, Cui L, Youngblood JM, Nakagami H, Liao JK, Liao R, Chin MT. Xiang F, et al. Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1997-2006. doi: 10.1152/ajpheart.01106.2005. Am J Physiol Heart Circ Physiol. 2006. PMID: 16603706 Free PMC article.

6

Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.

Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, Chin MT. Sakata Y, et al. Among authors: xiang f. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2069-74. doi: 10.1161/01.ATV.0000143936.77094.a4. Epub 2004 Sep 2. Arterioscler Thromb Vasc Biol. 2004. PMID: 15345511

7

A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice.

Wu K, Xiang F, Yuan J, Zeng Z, Zhou H, Chang S, Chen ZK. Wu K, et al. Among authors: xiang f. Transplant Proc. 2008 Dec;40(10):3699-701. doi: 10.1016/j.transproceed.2008.06.084. Transplant Proc. 2008. PMID: 19100468

8

Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.

Li G, Wu K, Tao K, Lu X, Ma J, Mao Z, Li H, Shi L, Li J, Niu Y, Xiang F, Wang G. Li G, et al. Among authors: xiang f. Mol Med Rep. 2015 Jul;12(1):760-8. doi: 10.3892/mmr.2015.3374. Epub 2015 Feb 18. Mol Med Rep. 2015. PMID: 25695487

9

Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.

Liu Y, Wu K, Shi L, Xiang F, Tao K, Wang G. Liu Y, et al. Among authors: xiang f. PLoS One. 2016 Nov 8;11(11):e0166230. doi: 10.1371/journal.pone.0166230. eCollection 2016. PLoS One. 2016. PMID: 27824926 Free PMC article.

10

Omental adipocytes enhance the invasiveness of gastric cancer cells by oleic acid-induced activation of the PI3K-Akt signaling pathway.

Xiang F, Wu K, Liu Y, Shi L, Wang D, Li G, Tao K, Wang G. Xiang F, et al. Int J Biochem Cell Biol. 2017 Mar;84:14-21. doi: 10.1016/j.biocel.2016.12.002. Epub 2016 Dec 9. Int J Biochem Cell Biol. 2017. PMID: 27956048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

855 results

Search Page

Filters